Back
BioNTech SE Quote, Financials, Valuation and Earnings
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
57
BNTX
BioNTech SE
Last Price:
113.22
Seasonality Move:
3.25%
7 Day Trial
ALL ACCESS PASS
$
7
Say this - unlock as much as $1,250 every Friday
Click here for full details.BioNTech SE Price Quote
$113.22
+0.09 (+4.61%)
(Updated: November 23, 2024 at 5:27 AM ET)
BioNTech SE Key Stats
Buy
57
BioNTech SE (BNTX)
is a Buy
Day range:
$107.41 - $114.32
52-week range:
$76.53 - $131.49
Dividend yield:
0%
P/E ratio:
27.28
P/S ratio:
8.27
P/B ratio:
1.27%
Volume:
1.2M
Avg. volume:
961.2K
1-year change:
15.49%
Market cap:
$27.1B
Revenue:
$4.1B
EPS:
$-2.11
How Much Does BioNTech SE Make?
-
How Much Are BioNTech SE's Sales Annually?
BNTX Revenues are $4.1B -
How Much Profit Does BioNTech SE's Make A Year?
BNTX net income is $1B
Is BioNTech SE Growing As A Company?
-
What Is BioNTech SE's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.4% -
What Is BioNTech SE's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0.24%
BioNTech SE Stock Price Performance
-
Did BioNTech SE Stock Go Up Last Month?
BioNTech SE share price went up by 2.03% last month -
Did BNTX's Share Price Rise Over The Last Year?
BNTX share price rose by 15.49% over the past 1 year
What Is BioNTech SE 52-Week High & Low?
-
What Is BioNTech SE’s 52-Week High Share Price?
BioNTech SE has traded as high as $131.49 over the past 52 weeks -
What Is BioNTech SE’s 52-Week Low Share Price?
BioNTech SE has traded as low as $76.53 over the past 52 weeks
BioNTech SE Price To Free Cash Flow
-
Is BioNTech SE Stock Overvalued?
BioNTech SE is trading at a price to free cash flow ratio of 26.49 -
Is BioNTech SE Stock Undervalued?
BioNTech SE EV to Free Cash Flow ratio is 8.47 -
What Is BioNTech SE’s Price Earnings Growth Ratio?
BNTX PEG ratio is 0.00 -
Is BioNTech SE Trading At A Premium To Earnings?
BioNTech SE EV to EBIT ratio is 0.00
Is It Risky To Buy BioNTech SE?
-
How Much Debt Does BioNTech SE Have?
Total long term debt quarterly is $272.2M -
How Much Cash Does BioNTech SE Have?
Cash and short term investments quarterly total is $18.7B -
What Is BioNTech SE’s Book Value Per Share?
Book value per share is 89.05
Is BioNTech SE Cash Flow Positive?
-
What Is BNTX Cash Flow From Operations?
Cash flow from operations (TTM) is $1.6B -
What Is BioNTech SE’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$51.7M -
What Is BioNTech SE’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$5.8B
BioNTech SE Return On Invested Capital
-
Is Management Doing A Good Job?
BNTX return on invested capital is -2.32% -
What Is BioNTech SE Return On Assets?
ROA measures how assets are converting to revenues and is -2.06% -
What Is BNTX Return On Equity?
ROE is a measure of profitability and is -2.35%
BioNTech SE Earnings Date & Stock Price
-
What Is BioNTech SE's Stock Price Today?
A single share of BNTX can be purchased today for 113.13 -
What Is BioNTech SE’s Stock Symbol?
BioNTech SE trades on the nasdaq under the ticker symbol: BNTX -
When Is BioNTech SE’s Next Earnings Date?
The next quarterly earnings date for BioNTech SE is scheduled on March 20, 2025 -
When Is BNTX's next ex-dividend date?
BioNTech SE's next ex-dividend date is June 2, 2022 -
How To Buy BioNTech SE Stock?
You can buy BioNTech SE shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
BioNTech SE Competitors
-
Who Are BioNTech SE's Competitors?
Below is a list of companies who compete with BioNTech SE or are related in some way:
BioNTech SE Dividend Yield
-
What Is BNTX Dividend Yield?
BioNTech SE’s dividend yield currently is 0% -
What Is BioNTech SE’s Payout Ratio?
BioNTech SE’s payout ratio is 0% -
When Did BioNTech SE Last Pay A Dividend?
The latest dividend pay date is November 24, 2024 -
What Is BioNTech SE’s Dividend Per Share?
BioNTech SE pays a dividend of $0.00 per share
BioNTech SE Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 23.97% | 150.43% |
| Revenue: | 40.45% | 141.23% |
Analyst Recommendations
| Buy Recommendations: | 10 |
|---|---|
| Hold Recommendations: | 4 |
| Sell Recommendations: | 0 |
| Price Target: | 135.69 |
| Upside from Last Price: | 19.94% |